Clinical and laboratory characteristics of male patients with primary biliary cirrhosis
[1]Lohse AW, zum Buschenfelde KH, Franz B, et al.Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and auto-immune hepatitis:evidence for it being a hepatitic form of PBC in ge-netically susceptible individuals[J].J Hepatology, 1999, 29 (4) ∶1078-1084.
|
[2]Joshi S, Cauch-Dudek K, Wanless IR, et al.Primary biliary cir-rhosis with additional features of autoimmune hepatitis:response to therapy with ursodeoxycholic acid[J].J Hepatology, 2002, 35 (2) ∶409-413.
|
[3]HeurguéA, Vitry F, Diebold MD, et al.Overlap syndrome of pri-mary biliary cirrhosis and autoimmune hepatitis:a retrospective study of115cases of autoimmune liver disease[J].J Gastroenterol Clin Bi-ol, 2007, 31 (1) ∶17-25.
|
[4]LF L, Adami HO, Sparèn P, et al.1994.Cancer risk in primary biliary cirrhosis:A population based study from Sweden[J].J Hepa-tology, 2005, 20 (1) ∶101-104.
|
[5]Nijhawan P K, Therneau T M, Dickson E R, et al.1999.Incidence of cancer in primary biliary cirrhosis:the Mayo experience[J].J Hepatology, 2003, 29 (5) ∶1396-1398.
|
[6]Jones D E, Metcalf J V, Collier J D, et al.1997.Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes[J].J Hepatology, 2003, 26 (5) ∶1138-1142.
|
[7]Shibuya A, Tanaka K, Miyakawa H, et al.Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis[J].J Hepatolo-gy, 2002, 35 (5) ∶1172-1178.
|
[1] | Yang Jun, Yu YaLi, Zheng ZhangQing. Clinical features of drug- induced liver injury and primary biliary cirrhosis: a comparative analysis[J]. Journal of Clinical Hepatology, 2016, 32(4): 728-731. doi: 10.3969/j.issn.1001-5256.2016.04.024 |
[2] | Fan YunYu, Sun LingYun. Association between smoking and risk of primary biliary cirrhosis: a meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1625-1629. doi: 10.3969/j.issn.1001-5256.2015.10.016 |
[3] | Yu Yuan, Yang ZongGuo, Chen ChiChi, Lu YunFei, Xu QingNian, Chen XiaoRong. Efficacy of adjuvant therapy with fenofibrate for primary biliary cirrhosis: a Meta-analysis[J]. Journal of Clinical Hepatology, 2015, 31(10): 1630-1633. doi: 10.3969/j.issn.1001-5256.2015.10.017 |
[4] | Zhu JiangYi, Han Ying. Research advances in primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(2): 163-164. doi: 10.3969/j.issn.1001-5256.2015.02.004 |
[5] | Huang ChunYang, Huang YunLi, Liu YanMin, Han Ying, Zhang XiaoDan, Zhao Peng, Liao HuiYu. Correlation between clinical data and pathological stage in patients with primary biliary cirrhosis: a study of 54 cases[J]. Journal of Clinical Hepatology, 2015, 31(2): 185-188. doi: 10.3969/j.issn.1001-5256.2015.02.010 |
[6] | Zhao DanTong, Liao HuiYu, Liu YanMin, Huang ChunYang, Zhang HaiPing, Sun LiMei, Ma YinXue, Zhao Yan, Yan HuiPing. ROC analysis of prognostic factors in Chinese patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(1): 62-66. doi: 10.3969/j.issn.1001-5256.2014.01.017 |
[7] | Li Bing, Shao Qing, Niu XiaoXia, Zhang Jian, Chen GuoFeng. Clinical features and diagnosis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J]. Journal of Clinical Hepatology, 2014, 30(5): 413-416. doi: 10.3969/j.issn.1001-5256.2014.05.007 |
[8] | Lu WeiTing, Jiang XingHuo, Guo HaiYan, Zhao JianXue. Clinical features of primary biliary cirrhosis: a clinical analysis of 70 cases[J]. Journal of Clinical Hepatology, 2013, 29(12): 926-928. doi: 10.3969/j.issn.1001-5256.2013.12.013 |
[9] | Gao HuiXia, Liu YuZhen, Lu JianHua, Ye LiHong, Dai ErHei. Correlation of Foxp3 + Tregs and TGFβ1 expression with inflammation in livers of patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2012, 28(12): 952-955. |
[10] | Liu MeiLing. Clinical analysis of primary biliary cirrhosis combined with diabetes mellitus[J]. Journal of Clinical Hepatology, 2011, 27(6): 635-637. |
[11] | Zhang Li, Bai ShiShan. Research progress on laboratory diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2011, 27(10): 1109-1111+1120. |
[12] | Zhao YanJuan, Sun ZheYing. The therapeutic effect of ursodeoxycholic acid capsules in patients with primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2010, 26(4): 432-433. |
[13] | Zhang Bo, Lu Yan, Cao Hong, Hu TaiHong. Progress in treatment and misdiagnosis of primary biliary cirrhosis [J]. Journal of Clinical Hepatology, 2010, 26(4): 441-442. |
[14] | Gao Feng, Zhang FuKui, Jia JiDong. Liver function changes of ursodeoxycholic acid made in china for patients with primary biliary cirrhosis.[J]. Journal of Clinical Hepatology, 2008, 24(4): 278-280. |
[16] | Tang ShuZhen, Liu XiaoMing, You Hong, Zhang FuKui, Wang BaoEn, Jia JiDong. Autoimmune related clinical tests in diagnosis of primary biliary cirrhosis[J]. Journal of Clinical Hepatology, 2006, 22(3): 191-192. |
[20] | He WenTao, Shi JianShi. Clinical analysis of primary bilary cirrhosis.[J]. Journal of Clinical Hepatology, 2001, 17(3): 180-181. |